相关实验视频
Updated: Jul 12, 2025

07:27
Implantation of Total Artificial Heart in Congenital Heart Disease
Published on: July 18, 2014
24.7K
末期心力衰竭:心脏移植和人工心脏的未来
Karl Bounader1, Erwan Flécher2
1Department of Cardiac Surgery, La Pitié Sâlpétrière Charles Foix Hospital, Paris, France.
概括
心脏移植是末期心力衰竭的黄金标准,但面临着移植缺口和免疫抑制风险. 机械循环支提供了一个替代方案,新的设备可能实现类似的结果.
科学领域:
- 心脏病学 心脏病学
- 医疗器械 医疗器械
- 手术创新 在外科创新.
背景情况:
- 心脏移植 (HTx) 和左心室辅助器件 (LVAD) 的结果有显著改善.
- HTx仍然是末期心力衰竭的黄金标准.
- HTx的限制包括移植稀缺性和长期免疫抑制并发症.
研究的目的:
- 审查心脏移植和LVADs的演变,当前状态和未来前景.
- 为了比较HTx和机械循环支持的治疗作用和结果.
- 探索LVADs与HTx达到平衡的潜力.
主要方法:
- 关于心脏移植和LVADs的文献综述.
- 对临床结果和设备进步的分析.
- 讨论治疗指示和长期管理.
主要成果:
- 心脏移植已被确立为末期心力衰竭的主要治疗方法.
- 作为桥梁到移植或目的地治疗,LVAD发挥着至关重要的作用.
- 在LVAD技术的进步可能会缩小与HTx的结果差距.
结论:
- 尽管面临挑战,心脏移植仍然是首选的治疗方法.
- 机械循环支持对于控制心力衰竭是不可或缺的.
- 未来的研究和设备创新是优化两种疗法结果的关键.
相关概念视频
Heart Failure VI: Adjunct Therapies
15
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
15
Cardiomyopathy V: Interprofessional Care
14
Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
14
Heart Failure IV: Classification and Diagnostic Evaluation
18
Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
18
Heart Failure V: Medical Management
9
Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
9
Cardiomyopathy II: Dilated Cardiomyopathy
11
Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
11
Heart Failure II: Pathophysiology
14
Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
14

